Abbott GmbH & Co.

  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    ALIMSA
  • 1 Event

One device in the database

  • Model / Serial
    ARCHITECT Intact PTH 8K25-01 Calibrator 006131000 05 SEP 2014 ARCHITECT Intact PTH 8K25-01 Calibrator 01913C000 14 MAR 2014 ARCHITECT Intact PTH 8K25-01 Calibrator 01913K000 12 NOV 2014 ARCHITECT Intact PTH 8K25-01 Calibrator 02413E000 09 MAY 2014 ARCHITECT Intact PTH 8K25-01 Calibrator 01312K000 12 NOV 2013 ARCHITECT Intact PTH 8K25-01 Calibrator 00813AOOO 08 JAN 2014 ARCHITECT Intact PTH 8K25-01 Calibrator 01412H000 16 AUG 2013 ARCHITECT Intact PTH 8K25-01 Calibrator 00912F000 30 MAY 2013 ARCHITECT Intact PTH 8K25-10 Control 007131000 05 SEP 2014 ARCHITECT Intact PTH 8K25-10 Control 01813C000 14 MAR 2014 ARCHITECT Intact PTH 8K25-10 Control 01813K000 12 NOV 2014 ARCHITECT Intact PTH 8K25-10 Control 02613E000 09 MAY 2014 ARCHITECT Intact PTH 8K25-10 Control 01412K000 12 NOV 2013 ARCHITECT Intact PTH 8K25-10 Control 00713A000 08 JAN 2014 ARCHITECT Intact PTH 8K25-10 Control 01012F000 30 MAY 2013 ARCHITECT Intact PTH 8K25-20 Reagent 00913F000 23 NOV 2014 ARCHITECT Intact PTH 8K25-20 Reagent 01313C000 21 AUG 2014 ARCHITECT Intact PTH 8K25-20 Reagent 01512K000 25 APR 2014 ARCHITECT Intact PTH 8K25-20 Reagent 01712H000 23 FEB 2014 ARCHITECT Intact PTH 8K25-20 Reagent 018131000 13 MAR 2015 ARCHITECT Intact PTH 8K25-20 Reagent 02213K000 08 MAY 2015 ARCHITECT Intact PTH 8K25-20 Reagent 01312G000 13 JAN 2014 ARCHITECT Intact PTH 8K25-20 Reagent 00512H000 13 JAN 2014 ARCHITECT Intact PTH 8K25-25 Reagent 00112K000 25 APR 2014 ARCHITECT Intact PTH 8K25-25 Reagent 01113C000 21 AUG 2014 ARCHITECT Intact PTH 8K25-25 Reagent 01313G000 05 JAN 2015 ARCHITECT Intact PTH 8K25-25 Reagent 01612H000 23 FEB 2014 ARCHITECT Intact PTH 8K25-25 Reagent 019131000 02 FEB 2015 ARCHITECT Intact PTH 8K25-25 Reagent 02213D000 05 OCT 2014 ARCHITECT Intact PTH 8K25-25 Reagent 00113K000 11 APR 2015 ARCHITECT Intact PTH 8K25-25 Reagent 01212G000 13 JAN 2014 ARCHITECT Intact PTH 8K25-25 Reagent 00412H000 13 JAN 2014 ARCHITECT Intact PTH 8K25-27 Reagent 00212K000 25 APR 2014 ARCHITECT Intact PTH 8K25-27 Reagent 01213C000 21 AUG 2014 ARCHITECT Intact PTH 8K25-27 Reagent 01413G000 05 JAN 2015 ARCHITECT Intact PTH 8K25-27 Reagent 01812H000 23 FEB 2014 ARCHITECT Intact PTH 8K25-27 Reagent 020131000 02 FEB 2015 ARCHITECT Intact PTH 8K25-27 Reagent 02313D000 05 OCT 2014 ARCHITECT Intact PTH 8K25-27 Reagent 00213K000 11 APR 2015 ARCHITECT Intact PTH 8K25-27 Reagent 01412G000 13 JAN 2014 ARCHITECT Intact PTH 8K25-27 Reagent 00612H000 13 JAN 2014

14 manufacturers with a similar name

Learn more about the data here

  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    NIDFSINVIMA
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    NZMMDSA
  • Manufacturer Address
    Abbott Gmbh & Co. KG, Max-Planck-Ring 2, 65205, Wiesbaden Germany
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    USFDA
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing. Note published by the authorities from the Netherlands: This message is a warning from the manufacturer. After placing a medical device on the market, the manufacturer is obliged to follow the device and, where necessary, to improve it. When there is a risk for the user, the manufacturer must take action. The manufacturer informs users and the inspection of this action with a warning (Field Safety Notice). See also medical device warnings. This is part of the supervision of medical technology.""Note published by the authorities from the Netherlands: This message is a warning from the manufacturer. After placing a medical device on the market, the manufacturer is obliged to follow the device and, where necessary, to improve it. When there is a risk for the user, the manufacturer must take action. The manufacturer informs users and the inspection of this action with a warning (Field Safety Notice). See also medical device warnings. This is part of the supervision of medical technology.
  • Source
    IGJ
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    BAM
9 more